SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-007570
Filing Date
2020-03-27
Accepted
2020-03-27 06:05:23
Documents
3
Period of Report
2020-03-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea120085-6k_alteritytherap.htm 6-K 13406
2 APPENDIX 2A AND SECTION 708A(5) CLEANSING ea120085ex99-1_alterity.htm EX-99.1 183266
3 GRAPHIC img_001.jpg GRAPHIC 12351
  Complete submission text file 0001213900-20-007570.txt   214911
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 20747762
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences